The Wilms' tumour 1 (WT1) gene encodes a zinc finger transcription factor that plays a central role in the development of the genitourinary, haematopoietic and central nervous systems [1, 2] 
another zinc finger transcription factor. Moreover, the zinc finger domain of WT1 mediates binding to DNA at the Egr1 consensus sequence 5ЈGCG(G/T)GGGCG3Ј, but its affinity for this site is somewhat less than that of Egr1 [11] . Additionally, WT1 has also been reported to bind to another motif, 5ЈGCGTGGGAGT3 Ј, termed the Wilms' tumour element (WTE) [12] . Depending on the cellular context and/or promoter, WT1 can act as either an activator or a repressor of transcription. For example, overexpression of WT1 in the human erythroleukaemia K562 cell line or in human breast cancer cell lines activated the c-Myc promoter [13] , whilst WT1 repressed the same promoter in HeLa cells [14] . WT1 can interact with other DNA-binding transcription factors, including p53 [15] , as well as specific co-activators, such as CBP [16] , or co-repressors, including BASP1 [17] , to regulate transcription. It is thought that it is the nature of binding of these co-factor partners that largely determines whether WT1 functions as a transcriptional activator or repressor.
The prostanoid thromboxane (TX) A2 plays a central role in haemostasis, acting as a potent mediator of platelet aggregation [18] , but can induce other diverse cellular responses including constriction of vascular and bronchial smooth muscle cells [18, 19] [20] . Moreover, in glomerulonephritis, a leading cause of end-stage renal failure, it is the most abundant eicosanoid synthesized in the nephritic glomeruli [21] . Alterations in the levels of TXA2 or the TXA2 receptor (TP) are associated with a variety of vascular disorders [22, 23] , inflammatory renal diseases [24] and in renal failure [25] .
. Within the kidney, TXA2 induces contraction of glomerular mesangial cells and intrarenal vascular tissue, decreasing glomerular filtration rates
In humans, TXA2 signals through two isoforms of the TXA2 receptor, termed TP␣ and TP␤, that are encoded by a single gene and arise by alternative splicing [26] [27] [28] . TP␣ and TP␤ are identical for their N-terminal 328 amino acid residues but differ exclusively in their C-tail domains [27, 28] . TP␣ and TP␤ regulate both common and distinct signalling pathways [26, [29] [30] [31] [32] [33] [34] [35] [36] . Hence, while the functional relevance for the existence of two TP receptors in primates is currently unknown, there is abundant evidence that they have distinct physiologic roles. Moreover, while TP␣ and TP␤ mRNAs are differentially expressed in a range of cell types [37] , platelets exclusively express TP␣ [38] . Consistent with this, TP␣ and TP␤ are transcriptionally regulated by distinct promoters, termed Prm1 and Prm3, respectively, within the single TP gene [39, 40] 
but are subject to entirely different modes of regulation, such as through both agonistdependent (homologous) desensitization and through intra-molecular cross-talk between other signalling systems

. A recent study aimed at characterizing Prm1 in HEL cells localized the proximal 'core' promoter and identified two upstream activator regions (UAR) and two upstream repressor regions (URR) within
Prm1 [41] . Therein [42, 43] and in renal (dys)function [1, 2] [45] . 
, the finding of its regulation of Prm1 and TP␣ expression may have important clinical implications.
Materials and methods
Materials pGL3Basic, pRL-Thymidine Kinase (pRL-TK) and Dual Luciferase® Reporter Assay System were obtained from Promega Corporation (Madison, WI, USA). DMRIE-C®, RPMI 1640 culture media and foetal bovine serum (FBS) were from Invitrogen Life Technologies (Carlsbad, CA, USA). Anti-WT1 (sc-192 X), anti-Sp1 (sc-59 X), anti-Egr1 (sc-
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Construction of luciferase-based genetic reporter plasmids
Western blot analysis
RT-PCR
Electrophoretic mobility shift and supershift assays
Nuclear extract was prepared from HEL cells as previously described [44] . [41] .
Chromatin immunoprecipitation assays
ChIP assays were performed using HEL 92.1.7 cells, as previously described [41] . Chromatin 
Statistical analysis
Statistical analyses of differences were analysed using the two-tailed Student's unpaired t-test. All values are expressed as mean Ϯ standard error of the mean (S.E.M.). P-values
Results
Identification of three distinct repressor regions within Prm1 of the human TP Gene
The ␣ and ␤ isoforms of TP are under the transcriptional regulation of Prm1 and Prm3, respectively, within the human TP gene [39] . Prm1 is defined as nucleotides -8500 to -5895 located 5Ј of the translation initiation codon within the human TP gene [39] . In a recent study aimed at characterizing Prm1 within the megakaryoblastic HEL 92. 1 
.7 cell line, two URR were identified (Fig. 1A and [41]). However, the factors regulating URR1 (-8500 to -7962) and URR2 (-6848 to -6648) remained to be identified (Fig. 1A and [41]). The aim of the current study was to further characterize Prm1 and to identify the cis-acting elements and trans-acting factors mediating its repression through the aforementioned URR1 and URR2 in HEL cells.
Initially, and consistent with previous findings [41] , genetic reporter assays and progressive 5Ј deletion of nucleotides from -8500 to -6648 to yield the core promoter (Prm1E; Fig. 1A 
Identification of multiple GC-enriched elements in the -8500 to -7962 repressor region of Prm1
Bioinformatic analysis [46] (Fig. 2) . Consistent with previous studies in K562 cells [47] , a doublet of WT1 protein at 52/54 kD was detected herein in HEL cells (Fig. 2A) . Also consistent with studies in K562 cells [48] , an immunoreactive Egr1 band of approximately 82 kD was detected in HEL cells (Fig. 2B) , while abundant expression of the ubiquitous Sp1 protein was also confirmed (Fig. 2C) (Fig. 3) . It has been well documented that both Egr1 and WT1 proteins can bind to the Egr1 consensus sequence [11] , while it has also been suggested that the WTE may act as a specific binding element for WT1 [12] . Moreover, overlapping sites for Sp1 and Egr1/WT1 are frequently found in promoter sequences due to the similarity in their consensus elements [49] .
Incubation of biotin-labelled oligonucleotide probes encoding GC Ϫ8345 and GC Ϫ8281 (Fig. 3A and B (Fig. 3F) . Overall, these EMSA data (Fig. 3) (Fig. 4) (Fig. 4B) (Fig. 4C) .
Fig. 4 Chromatin immunoprecipitation (ChIP) analysis of WT1, Sp1 and/or Egr1 binding to the 5Ј region of Prm1 and effect of overexpression of WT1 on Prm1-directed luciferase expression. (A)-(C): ChIP analysis of WT1, Sp1 and/or Egr1 binding to Prm1 in HEL 92.1.7 cells. Schematic of Prm1 and primers (arrows) used in the PCR to amplify the -8460 to -8006 (A) or the -7978 to -7607 (B) regions of Prm1 using either input chromatin or chromatin extracted from anti-WT1, anti-Egr1, anti-Sp1 or, as a control, normal rabbit IgG immunoprecipitates. Primers to detect a region of Prm3 (-1081 to -695; C) from input chromatin, anti-Sp1, anti-Egr1, anti-WT1 or normal rabbit IgG precipitates were used as a negative control. Images are representative of three independent experiments. (D) and (E): HEL cells were transiently co-transfected with either 0.5 g of pcDNA3 (control) or 0.5 g of recombinant pcDNA3 encoding (ϩ/ϩ), (ϩ/-), (-/ϩ) or (-/-) isoforms of WT1, along with pGL3b:Prm1 (1.5 g) plus pRL-TK (200 ng). Cells were either assayed 48 hrs after transfection for mean luciferase activity (RLU Ϯ S.E.M.; n ϭ 9) or subjected to Western blot analysis (40 g whole cell protein per lane). The size of WT1 isoforms are indicated to the left of the panel. (F) and (G): RT-PCR analysis using primers to amplify TP␣ and GAPDH mRNA sequences from total RNA isolated from HEL cells following transfection with 0.5 g of pcDNA3 (control) or 0.5 g of recombinant pcDNA3 encoding either the (ϩ/-) or (-/-) isoform of WT1. Densitometric analysis (G) was carried out to assess the relative expression of TP␣ mRNA to GAPDH mRNA in HEL cells transfected with pcDNA3 (control) or recombinant pcDNA3 encoding either the (ϩ/-) or (-/-) isoform of WT1. chromatin, anti-WT1 and, to a much lesser extent, from anti-Egr1 immunoprecipitates. However, these primers failed to amplify DNA from anti-Sp1 or control IgG precipitates
Hence, to expand these studies, the effect of ectopic expression of WT1 on Prm1-directed reporter gene expression and TP␣ mRNA was investigated (Fig. 4D- 
G). The four main isoforms of WT1, specifically (ϩ/ϩ), (ϩ/-), (-/ϩ) and (-/-) with respect to the presence or absence of exon 5 and KTS sequences, respectively, were over-expressed in HEL cells (Fig. 4E) and the effects on Prm1-directed luciferase activity were investigated. While immunoblot analysis confirmed overexpression of WT1 (Fig. 4E), the (ϩ/-) and (-/-) isoforms led to 1.4-fold (P ϭ 0.0013) and 1.7-fold (P ϭ 0.0007) reductions in Prm1-directed luciferase expression, respectively, while neither the (ϩ/ϩ) nor (-/ϩ) isoforms had any significant effect (P ϭ 0.4817 and P ϭ 0.8881; Fig. 4D). Consistent with this, RT-PCR confirmed that ectopic expression of the transcriptionally active (ϩ/-) and (-/-) isoforms both reduced TP␣ mRNA expression with no substantial changes in GAPDH expression (Fig. 4F). Moreover, densitometric analysis revealed that ectopic expression of (ϩ/-) and (-/-) isoforms led to significant decreases in TP␣ mRNA expression relative to GAPDH mRNA expression, compared to HEL cells transfected with a control plasmid (P ϭ 0.0167, P ϭ 0.0080; Fig. 4G). Taken together, these data indicate that -KTS isoforms of WT1 mediate repression of Prm1 and TP␣ expression and considering the data from mutational, EMSA and ChIP analyses, it appears that WT1 exerts this repression by binding to GC elements at -8345, -8281, -8146 and -7831.
Identification of GC elements in the -6848 to -6648 and -6258 to -6123 repressor regions of Prm1
Amongst the transcription factor binding elements identified within URR2 located between -6848 and -6648 (Fig. 1A) (Fig. 5B) . The luciferase activity directed by Prm1D GC* (-6717,-6206) , in which both GC elements at -6717 and -6206 were mutated, was significantly higher than that of either Prm1D GC* (-6717) , in which the -6717 element alone was mutated, or Prm1D GC* (-6206) , in which the -6206 element alone was mutated (P Ͻ 0.0001 in each case [12] 5Ј GcGGGGGCG 3Ј
WTE [12] 5Ј gtgcGTGGGaGtagaat 3Ј
Sp1 consensus [66] 5Ј gGGGCGGGgc 3Ј (Fig. 6G) . Thereafter, the effects of ectopic expression of WT1 on luciferase activity directed by Prm1D (-6848) 
Fig. 6 Nuclear factor binding to GC Ϫ6717 and GC Ϫ6206 elements within Prm1 in vitro and in vivo and effect of overexpression of WT1 on Prm1D and
Prm1I-directed luciferase expression. (A, B, D, E): EMSAs (A and D) and supershift assays (B and E) using nuclear extract from HEL cells and a biotinylated double-stranded probe encoding (A and B) the Prm1 GC Ϫ6717 element and (D and E) the Prm1 GC Ϫ6206 element, where the location of the specific probe within Prm1 is indicated by the horizontal bar. (A) and (D): Nuclear extract was pre-incubated with vehicle (-) or excess non-labelled competitor oligonucleotides (ϩ) before addition of the specific probe. One complex, C1, was observed in each case. (B) and (E): Nuclear extract was preincubated with anti-Sp1, anti-Egr1, anti-WT1 or, as a negative control, anti-cJun prior to addition of the relevant probe. The images are representative of three independent experiments. (C, F and G): chromatin immunoprecipitation (ChIP) analysis and schematic of Prm1 and primers (arrows) used in the PCR to amplify the -6848 to -6437 (C) and the -6368 to -5895 (F) regions of Prm1 from input chromatin or from chromatin extracted from anti-WT1, anti-Egr1, anti-Sp1 or, as a control, normal rabbit IgG immunoprecipitates, as indicated. Primers to detect a region of Prm3 (-1081 to -695; G) from input chromatin, anti-WT1, anti-Egr1, anti-Sp1 or normal rabbit IgG precipitates were used as a negative control. The images are representative of three independent experiments. (H and I): HEL cells were transiently co-transfected with either 0.5 g of pcDNA3 (control) or 0.5 g of recombinant pcDNA3 encoding (ϩ/ϩ), (ϩ/-), (-/ϩ) or (-/-) isoforms of WT1, along with pRL-TK (200 ng) and 1.5 g of either pGL3b:Prm1D (H) or pGL3b:Prm1I (I). Cells were assayed for 48 hrs after transfection for mean luciferase activity (RLU Ϯ S.E.M.; n ϭ 9). The asterisks (*) indicate that overexpression of WT1 significantly reduced Prm1D-directed luciferase expression in HEL cells
, where ** indicates P Ͻ 0.01. 
were investigated. The (ϩ/ϩ), (ϩ/-), (-/ϩ) and (-/-) isoforms of WT1 were over-expressed in HEL cells. The (ϩ/-) and (-/-) iso
Discussion
In humans, TXA2 signals through two isoforms of its cognate GPCR, termed TP␣ and TP␤ [26] [27] [28] . Imbalances in the levels of TXA2 and TP have been implicated in a number of vascular and pulmonary disorders [22, 23] , as well as in inflammatory renal diseases and in renal failure [24, 25] . Since distinct promoters control transcription of TP␣ and TP␤ [39, 40] [15, 52] , IGFI receptor [53] , IGFII [54] and PDGF-A [55] , as well as mediating auto-repression of its own gene [56] . Additionally, WT1 is thought to be an important factor in the regulation of haematopoiesis. Although it is highly expressed in a subset of CD34ϩ progenitors, it is down-regulated early in the course of differentiation of these cells [43] . Additionally, WT1 mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of the K562 cell line [57] . Recently, -KTS isoforms of WT1 have been confirmed to act as transcriptional regulators during haematopoiesis, where they activate transcription of the erythropoietin receptor [58] . Moreover, increased expression of WT1 has been reported to occur in acute human leukaemias [59] .
Considering (Fig. 7C) . Therefore, it is suggested that disruption of remaining elements results in de-activation of the promoter (Fig. 7D) 
